Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

BACKGROUND: Oncolytic viral therapy represents an alternative therapeutic strategy for the treatment of cancer. We previously described GLV-1h68, a modified Vaccinia Virus with exclusive tropism for tumor cells, and we observed a cell line-specific relationship between the ability of GLV-1h68 to rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Maria Libera, Worschech, Andrea, Yu, Zhiya, Adams, Sharon, Reinboth, Jennifer, Chen, Nanhai G, Pos, Zoltan, Roychoudhuri, Rahul, Di Pasquale, Giovanni, Bedognetti, Davide, Uccellini, Lorenzo, Rossano, Fabio, Ascierto, Paolo A, Stroncek, David F, Restifo, Nicholas P, Wang, Ena, Szalay, Aladar A, Marincola, Francesco M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213037/
https://www.ncbi.nlm.nih.gov/pubmed/22011439
http://dx.doi.org/10.1186/1471-2407-11-451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213037/
https://www.ncbi.nlm.nih.gov/pubmed/22011439
http://dx.doi.org/10.1186/1471-2407-11-451

Ejemplares similares